Clincosm LogoSign in Get a demo

parosmia

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parosmia Trial in London (Stellate Ganglion Block, Placebo)

Not yet recruiting
  • Parosmia
  • Stellate Ganglion Block
  • Placebo
  • London, Ontario, Canada
    St. Joseph's Hospital London
Sep 22, 2023

COVID-19-Associated Olfactory Dysfunction, Anosmia, Hyposmia Trial (Stellate Ganglion Block)

Completed
  • Anosmia
  • +3 more
  • Stellate Ganglion Block
  • Saint Louis, Missouri
    Washington University School of Medicine/Barnes Jewish Hospital
Jan 5, 2023

Anosmia, Covid19, Hyposmia Trial in Roma (co-ultraPEALut, Olfactory Rehab)

Completed
  • Anosmia
  • +4 more
  • co-ultraPEALut
  • +3 more
  • Roma, Italy
    Multicentric
Nov 12, 2022

COVID-19, Olfactory Disorder, Anosmia Trial in Saint Louis (Gabapentin gelatin capsules 300mg, Placebo)

Enrolling by invitation
  • COVID-19
  • +4 more
  • Gabapentin gelatin capsules 300mg
  • Placebo
  • Saint Louis, Missouri
    Washington University
Jun 16, 2022

Hyposmia, COVID-19, Parosmia Trial in Trois-Rivières (Smell training)

Recruiting
  • Hyposmia
  • +4 more
  • Smell training
  • Trois-Rivières, Quebec, Canada
    Université du Québec à Trois-Rivières
May 20, 2022

Triggers for Post-Viral Parosmia

Suspended
  • Parosmia
  • Smell Disorder
    • Reading, United Kingdom
      University of Reading
    Sep 5, 2021